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 1
 INTRODUCTION 
 
Diabetes is severe disease affecting over hundred millions of people 
endure from diabetes with in the world. In USA about 16 million people are 
affected from diabetes.  
 
It affects all age group from children to elderly individual by type II 
Diabetes have greater damage of nerve ,kidney, eye and coronary heart 
diseases. 
 
Diabetes believed to be the national IV leading for death. In the 
nervous system could also be disturbed or damaged causing severe pain, loss 
of felling this situation is referred to neuropathy                                                                    
 
Diabetic neuropathy is a complication caused by diabetes symptoms 
includes numbness and some time pain in the hand, feet or in legs  
           
Peripheral neuropathy is a problem with the nerve that carry 
information to and from the brain and spinal cord this produce pain loss of 
sensation and in ability to control muscle. 
 
 Peripheral means away from the center of the body distance from 
spinal cord, ‘neuro” means nerve, ‘pathy’ means abnormal about 60 to 70% 
of diabetic patient have mild to severe form of nervous system damage 
which leads to diabetic poly neuropathy.      
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 Peripheral nerves, called sensory nerves,sents messages (stimuli) to 
the brain and spinal cord, so we can feel certain sensations. For example, 
when we prick our finger, sensory nerves transmit this information to the 
brain and we will feel a sharp sensation. Someone with sensory nerve 
damage may feel numbness rather than pain. 
 
 Prevalence - the projected 18 millions of people increases in the 
number of cases of diabetes in 2050, 37% are due to changes in 
demographic composition, 27% are due to population growth, and 36% are 
due to increasing rates. 
                                                                                                      
 Diabetic neuropathy is classified as peripheral, autonomic proximal 
(or) focal, peripheral neuropathy is the most common type of diabetic 
neuropathy and also called as distal symmetric neuropathy or sensorimotor 
neuropathy. Peripheral neuropathy affects nerves of toes, feet, legs, hands & 
arms. Feet & legs are likely to be affected before hands and arms. 
 
The first treatment is to bring sensation back by bringing the blood 
sugar level with in the normal range to prevent further nerve damage. 
Diabetic peripheral neuropathy is treated with medication and physiotherapy 
treatment modality like TENS, external electrical muscle stimulation and 
exercises. 
This study was carried out to determine the effectiveness of External 
Electrical Muscle Stimulator and Transcutaneous electrical nerve stimulation 
(TENS)in Management of Diabetic Peripheral Neuropathy using Neuropathy 
Total Symptom Score-6 (NTSS-6) and LEFS. 
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AIMS AND OBJECTIVES 
 
AIM OF THE STUDY  
 
 To compare the effectiveness of External Electrical Muscle 
Stimulator and Transcutaneous electrical nerve stimulation in Management 
of Diabetic Peripheral Neuropathy.  
 
OBJECTIVES OF THE STUDY 
 
¾ To determine the effectiveness of External Electrical Muscle 
Stimulator in Diabetic Peripheral Neuropathy. 
 
¾ To determine the effectiveness of transcutaneous electrical nerve 
stimulation in Diabetic Peripheral Neuropathy. 
 
¾ To compare the effects of External Electrical Muscle Stimulator and 
Transcutaneous electrical nerve stimulation in Management of 
Diabetic Peripheral Neuropathy in sensory reeducation.    
 
¾ To compare the effects of External Electrical Muscle Stimulator and 
Transcutaneous electrical nerve stimulation in Management of 
Diabetic Peripheral Neuropathy using lower extremity functional 
scale. 
 
¾ To find out the effective treatment regarding pain, functional status, 
and sensation in Diabetic Peripheral Neuropathy. 
 4
HYPOTHESIS 
 
NULL HYPOTHESIS  
 
 The null hypothesis states that there was no significant difference 
between External Electrical Muscle Stimulation Versus Transcutaneous 
electrical nerve stimulation in the Management of Diabetic Peripheral 
Neuropathy. 
 
ALTERNATE HYPOTHESIS  
 
 The alternate hypothesis states that there was significant difference 
between External Electrical Muscle Stimulation Versus Transcutaneous 
electrical nerve stimulation in the Management of Diabetic Peripheral 
Neuropathy. 
 
 
 
 
 
 
 
 
 
 
 
 5
REVIEW OF LITERATURE 
 
¾ L.Reichstein et. al.,(Apr 2005) 
 
The aim of the study was to find out the effectiveness of high 
frequency external muscle stimulation versus TENS on symptomatic 
diabetic neuropathy .41 patient who is suffering from diabetes in which 20 
patients with out pain and 21 patients with pain duration of treatment 30 min 
daily for 3 consecutive days for both lower extremities .The parameter used 
are HbA1c (mmol/l) and Neurological impairment scale. The result of the 
study say that high frequency external muscle stimulation can ameliorate the 
discomfort pain, reduction in HbA1c,improvement in Neurological 
impairment scale  associated with diabetic peripheral neuropathy than 
TENS. 
 
The conclusion of the study shows that external muscle stimulation is 
more effective than TENS for diabetic sensory polyneuropathy. 
 
¾ Per M.Humpert MD et al (Jan 2009) 
 
The aim of the study to find out the effect of external muscle 
stimulation in improving burning sensation  and sleeping disturbance in 
patient with type 2 diabetes with symptomatic neuropathy. About 92 patients 
with type 2 diabetes with neuropathy symptomatic are taken for study. 
Patient treated with EMS twice a week for 4 weeks. The parameter used 
numerical scale. 
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  The result of the study shows that about 73% of patients is marked 
improvement in numerical scale of symptoms such as pain, burning 
sensation, numbness, sleeping disturbance and paresthesia. 
 
 The Study concluded that external muscle stimulation is an effective  
treatment for symptomatic neuropathy patient with type 2 diabetes. 
 
¾ Peter EJ et al (oct.1998) 
 
       The purpose of the study was to evaluate electrical stimulation on 
vascular perfusion in diabetic patients. About 19 patients were selected 
based on transcutaneous oximeter. The parameter used is Transcutaneous 
oximeter values of which vascular perfusion was measured before and after 
external muscle stimulation for a period of two days.   
 
  The study result shows that external muscle stimulation induces 
transient rise in skin perfusion in patient with diabetes. 
 
   The study concluded that external muscle stimulation is an effective 
treatment for symptomatic neuropathy patient with type 2 diabetes. 
 
¾ MD Edward et al (oct. 2005) 
 
The study was conducted to find out the development     and validity 
testing of the neuropathy total symptom score-6 (NTSS-6) questionnaires for 
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the study of sensory symptoms of diabetic poly neuropathy. About 205 
patients where used in 10 centers in USA. 
 
The study concluded that neuropathy total symptom score-6 was valid 
assessment of neuropathy sensory symptoms of patients with diabetes and 
diabetic polyneuropathy. It is more reliable and valid to evaluate diabetic 
polyneuropathy in this well defined world. 
 
¾ Moharic et al (Sep. 2010) 
                
 Aim of the study was conducted to determine the effectiveness of 
TENS in painful neuropathy condition. About 46 patients was treated with 
tens for 3 consecutive hours for 3 weeks. Treatment effect was evaluated by 
cold, warm ,cold pain threshold ,heat pain threshold, vibration perception 
threshold and touch perception threshold. 
 
          The result concluded that there is no statistically significant changes in 
cold, warm ,cold pain threshold ,heat pain threshold, vibration perception 
threshold and touch perception threshold. It does not alter C fibers, A (delta), 
nor A (beta) fibers mediated perception threshold. 
 
Study concluded that TENS does not alter above fibers mediated 
perception threshold in diabetic peripheral neuropathy.  
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¾ Rose b et. al.,(2006) 
 
 The aim of the study was to evaluate the beneficial effect of external 
muscle stimulation on glycaemic control in patient with type 2 diabetes .In 
this study 16 patients on antihyperglycemic drug 6weeks of High frequency 
external muscle stimulation. The parameter’s used are HbA1c, blood 
samples where drawn.  
 
          The result of study shows that there is a reduction of blood sugar 
level, body weight and HbA1c (-0.4%) in the patient with type2 diabetes. 
 
           The study concludes that EMS is an additional treatment option for 
patients with type two diabetes who can not perform physical activity. 
  
¾ E Hultman and LL Spriet (may. 1985) 
 
         The study was conducted to evaluate the skeletal muscle metabolism, 
contraction force and glycogen utilization during prolonged electrical 
stimulation in human quadriceps muscles of 7 volunteer’s duration of 45 min 
of electrical stimulation titanic trains at 20Hz lasting 1.6s separated by 1.6s 
pause. Muscle biopsies where taken at rest and during stimulation that 
reduces blood glucose level in diabetic patients. The parameter used is 
muscle biopsies during rest and during stimulation. 
 
        The study result conclude that external stimulation increases the 
skeletal muscle metabolism 
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¾ M Lankisch et al 
                
The aim of the study was to determine the new possibilities of 
treatment for type 2 diabetes by means of external muscle stimulation. It’s a 
12 week in these 2 weeks of external muscle stimulation. The electrode is 
placed over the thigh and shunk .The GLUT 1 and GLUT 4, body weight 
and HbA1c used as parameters . 
 
          The study result states that there is body mass index and HbA1c is 
reduced and increase in GLUT 1 and GLUT 4. 
 
           The study concluded that external muscle stimulation is clinically 
relevant to patients with type 2 diabetes could be demonstrated. 
 
¾ Deephika Sharma et al (Oct 2010) 
 
The study was to evaluate the effect of external muscle stimulation on 
blood sugar level and lipid profile of sedentary type 2 diabetes patients. 
About 20 patients under gone electrical stimulation over quadriceps muscles 
40 min/day/3 days/ week for continuous 2 weeks . Parameter blood test was 
taken on 1st and last day of treatment.  
 
          The study result concludes that blood sugar level is reduced by means 
of external muscle stimulation in type 2 diabetic patients.  
 
The study concluded that external muscle stimulation is clinically 
relevant to patients with type 2 diabetes could be demonstrated 
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¾ Jill M Binkley et al (Jan. 1999) 
 
The purpose of this study was to assess the reliability, construct 
validity, and sensitivity to change of the Lower Extremity Functional Scale. 
About 107 patients with lower-extremity dysfunction .  
 
           The study result states that Lower Extremity Functional Scale was 
excellent. 
 
           Conclusion and Discussion . The Lower Extremity Functional Scale 
is reliable, and construct validity was supported by comparison with the SF-
36. The sensitivity to change of the Lower Extremity Functional Scale was 
superior to that of the SF-36 in this population. The Lower Extremity 
Functional Scale is efficient to administer and score and is applicable for 
research purposes and clinical decision making for individual patients. 
 
¾ MD Edward J Bastyr III 12(July 2005) 
 
           The aim of this study was to develop and validate a neuropathy 
sensory symptom scale, the Neuropathy Total Symptom Score-6 (NTSS-6), 
which evaluates individual neuropathy sensory symptoms in patients with 
diabetes mellitus (DM) and diabetic peripheral neuropathy (DPN) in clinical 
trials. 
 
         The parameter’s used are numbness and/or insensitivity; prickling 
and/or tingling sensation; burning sensation; aching pain and/or tightness; 
sharp, shooting, lancinating pain; and allodynia and/or hyperalgesia. 
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            The study result conclude that the Neuropathy Total Symptom Score-
6 (NTSS-6)provided a valid assessment of neuropathy sensory symptoms in 
this sample of patients with diabetes mellitus and diabetic peripheral 
neuropathy, which suggests that it may be useful for symptom evaluation in 
clinical trials and practice. The Neuropathy Total Symptom Score-6 (NTSS-
6) showed internal consistency, test-retest reliability, and construct validity. 
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MATERIALS AND METHDOLOGY 
 
 
MATERIALS  
 
¾ Couch. 
¾ Pillows. 
¾ External Electrical Muscle Stimulator. 
¾ Transcutaneous Electrical Muscle Stimulator(TENS) 
¾ Electrode gel.  
¾ Strap. 
¾ Cotton. 
¾ Lower extremity functional scale and Neuropathy Total Symptom 
Score-6 chart. 
 
METHODOLOGY  
Study Design  
 Quasi Experimental Study Design. 
 
 
Study Setting 
 
 The study was conducted at out patient department in J.K.K. 
Munirajahh Medical Research Foundation College of Physiotherapy, 
Komarapalayam under the supervision of the higher concerns. 
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Sampling Method 
 
 Convenient sampling method. 
 
Sample Size 
 
 Thirty patients with diabetic peripheral neuropathy, who comes under 
the inclusion criteria, were taken for the study. 
 
Study Duration 
 
 The study was conducted for a course of 6 months, and treatment 
duration for each patient was 20 min per sitting, 4 sittings per week for one 
month. 
 
Inclusion Criteria 
 
¾ Age group –50 years and above. 
¾ Sex – both sexes. 
¾ Diabetic peripheral neuropathy. 
¾ HbA1(C) <8. 
¾ Neuropathy Disability Score (NDS) <6 
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Exclusion Criteria 
 
¾ Pregnancy. 
¾ Malignancy. 
¾ vessel involvement. 
¾ Patient with cardiac pacemaker. 
¾ Infective skin lesion 
¾ Varicose vein. 
¾ Presence of ulcer. 
¾ Insulin dependent diabetes mellitus. 
¾ HbA1(C)>8. 
¾ Amputation 
 
Parameters  
 
¾ Neuropathy Total Symptom Score-6 (NTSS-6)  
¾ Lower Extremity Functional Scale. 
 
Procedure 
 
A total number of 30 patients having Diabetic peripheral neuropathy 
who met the inclusion criteria were recruited by convenient sampling 
method. After the informed consent obtained, they were partitioned into two 
groups as Group A and Group B, with 15 patients in each. 
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 Hence prior to the onset of treatment, pre-tests were conducted using 
Neuropathy Total Symptom Score-6 and Lower Extremity Functional Scale 
and results were recorded for both groups. 
 
 
Statistical Tools 
Paired‘t’ test: 
The paired‘t’ test was used to find out the statistical significance 
between pre and post test of patients treated with external electrical muscle 
stimulation and TENS. 
Formula: Paired‘t’ test: 
   s = 
1
)( 22
−
−∑ ∑
n
n
d
d
 
   t = 
s
nd  
 
   d = difference between pre test Vs post test values  
  d  = mean difference  
 n = total number of subjects 
 s = standard deviation. 
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Unpaired‘t’ test: 
The unpaired‘t’ test was used to compare the statistically significant 
difference between Group A and Group B. 
Formula: Unpaired‘t’ test: 
s =  
2
)1()1(
21
2
22
2
11
−+
−+−
nn
snsn  
 
  t = 
2
1
1
1
21
// nns
xx
+
−
 
 
n1      = total number of subjects in group A  
n2      = total number of subjects in group B 
1x       = difference between pre test Vs post test of group A 
1x      = mean difference between pre test Vs post test of           
           Group A 
           2x     = difference between pretest Vs post test of group B 
           2x     = mean difference between pre test Vs post test of  
             Group B 
s = standard deviation. 
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DATA PRESENTATION 
 
TABLE I 
 
 
 
S.No 
Group A 
Transcutaneous electrical nerve 
stimulation 
Group B 
External Electrical Muscle 
Stimulator 
Neuropathy Total 
Symptom Score-6 
(NTSS-6) 
Lower 
Extremity 
Functional 
Scale (LEFS) 
Neuropathy 
Total Symptom 
Score-6 (NTSS-6) 
Lower 
Extremity 
Functional 
Scale(LEFS) 
Pre Post Pre Post Pre Post Pre Post 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
12 
11 
12 
10 
11 
9 
10 
11 
11 
12 
11 
10 
10 
11 
12 
7 
6 
5 
6 
6 
5 
6 
6 
6 
8 
7 
6 
5 
6 
7 
35 
36 
38 
37 
40 
41 
42 
43 
37 
36 
40 
41 
35 
36 
44 
55 
51 
52 
55 
59 
57 
60 
58 
50 
49 
61 
60 
51 
50 
60 
10 
11 
12 
12 
10 
11 
9 
9 
11 
10 
12 
11 
11 
9 
8 
2 
3 
2 
3 
2 
3 
2 
2 
2 
2 
3 
3 
3 
2 
2 
39 
37 
38 
35 
41 
40 
42 
44 
45 
43 
35 
36 
37 
39 
38 
75 
71 
70 
69 
68 
74 
72 
69 
73 
70 
74 
75 
68 
69 
71 
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DATA ANALYSIS AND INTERPRETATION. 
 
 This section deals with the analysis and interpretation of data 
collected from group A and Group B who underwent Transcutaneous 
electrical nerve stimulation and External electrical muscle stimulator 
TABLE – II 
Group – A 
 Table II represents the mean values, mean difference, standard 
deviation, and paired ‘t’ value between pre test Vs post test values of Patient 
Rated diabetic peripheral neuropathy for group A who have been subjected 
to Transcutaneous electrical nerve stimulation. 
NTSS-6 Mean 
Mean 
difference 
Standard 
deviation 
Paired ‘t’ 
value 
Pre test 
 
Post test 
10.86 
 
6.1 
4.76 0.79 23.02 
 
 It shows the analysis of Patient Rated Diabetic Peripheral Neuropathy; 
the paired ‘t’ value of pre Vs post sessions of group A was 23.02 at 0.05 
level of significance, which was greater than the tabulated value of 2.15. 
This showed that there was a statistical significant difference in between pre 
Vs post test results. The pre test mean was 10.86, the post test mean was 6.1 
and mean difference was 4.76, which showed that there was a decrease in 
Patient Rated Diabetic Peripheral Neuropathy in post test indicating the 
recovery of selected samples in response to intervention. 
 19
 
Graph I – Patient-Rated diabetic polyneuropathy Evaluation of Group 
A 
 
10.86
6.1
0
20
40
60
80
100
N
T
SS
-6
PRE POST
 
Pre & Post test values 
 20
 
TABLE - III 
Group – B 
 
 Table III represents the mean values, mean difference, standard 
deviation, and paired‘t’ value of Patient Rated Diabetic Peripheral 
Neuropathy for group B, who have been subjected to External Electrical 
Stimulation.  
  
NTSS-6 Mean 
Mean 
difference 
Standard 
deviation 
Paired ‘t’ 
value 
 
Pre test 
 
Post test 
 
10.40 
 
2.40 
 
 
 
8 
 
 
1 
 
 
30.98 
 
 Table III shows the analysis of Patient Rated Diabetic Peripheral 
Neuropathy; the paired ‘t’ value of pre Vs post sessions of group B was 
30.98 at 0.05 level of significance, which was greater than the tabulated 
value of 2.15. This showed that there was a statistical significant difference 
in between pre Vs post test results. The pre test mean was 10.40, the post 
test mean was 2.40 and mean difference was 8 , which showed that there 
was a decrease in Patient Rated Diabetic Peripheral Neuropathy in post test 
indicating the recovery of selected samples in response to intervention 
 21
 
Graph II – Patient-Rated diabetic polyneuropathy Evaluation of Group 
B 
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TABLE – IV 
 Table IV represents the comparative mean values, mean difference, 
standard deviation, and unpaired‘t’ value between group A and group B on 
Patient Rated Diabetic Peripheral Neuropathy. 
 
NTSS-6 Mean 
Mean 
difference 
Standard 
deviation 
Unpaired ‘t’ 
value 
 
Group A 
 
Group B 
 
4.76 
 
8 
 
 
3.24 
 
 
0.895 
 
 
9.92 
 
 Table IV shows the analysis of group A and group B with Patient 
Rated Diabetic Peripheral Neuropathy. The unpaired‘t’ value of 9.92 was 
greater than the tabulated ‘t’ value of 2.05 at 0.05 level of significance which 
showed that there was statistically significant difference between group A 
and group B. The mean value of group A was 4.76 and the mean value of 
group B was 8, which showed that there was a greater improvement in group 
B than group A. 
 
Therefore, the study is rejecting the null hypothesis and accepting the 
alternate hypothesis. 
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Graph III - Mean difference of Group A and Group B  NTSS-6 
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TABLE - V 
Group – A 
 
 Table V represents the mean values, mean difference, standard 
deviation, and paired ‘t’ value between pre test Vs post test values of 
Diabetic Peripheral Neuropathy for group A who have been subjected to 
Transcutaneous electrical nerve stimulation.   
 
LEFS Mean 
Mean 
difference 
Standard 
deviation 
Paired ‘t’ 
value 
 
Pre test 
 
Post test 
 
38.73 
 
55.30 
 
 
16.57 
 
 
2.472 
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 Table V shows the analysis of lower extremity functional scale.; the 
paired ‘t’ value of pre Vs post sessions of group A was 26 at 0.05 level of 
significance, which was greater than the tabulated value of 2.15. This 
showed that there was a statistical significant difference in between pre 
Vs post test results. The pre test mean was 38.73 , the post test mean was 
55.30 and mean difference was 16.57 , which showed that there was an 
increase in lower extremity functional scale  in post test indicating the 
recovery of selected samples in response to intervention. 
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Graph IV– LEFS of Group A 
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TABLE - VI 
Group – B 
 
 Table VI represents the mean values, mean difference, standard 
deviation, and paired ‘t’ value of lower extremity functional scale. 
For group B, who have been subjected to External electrical muscle 
stimulator. 
.   
LEFS Mean 
Mean 
difference 
Standard 
deviation 
Paired ‘t’ 
value 
 
Pre test 
 
Post test 
 
39.27 
 
71.20 
 
 
31.93 
 
 
4.245 
 
 
28.99 
 
 Table VI shows the analysis of lower extremity functional scale, the 
paired ‘t’ value of pre Vs post sessions of group B was 28.99  at 0.05 level 
of significance, which was greater than the tabulated value of 2.15. This 
showed that there was a statistical significant difference in between pre Vs 
post test results. The pre test mean was 39.27-, the post test mean was 71.20 
and mean difference was 31.93, which showed that there was an increase in 
lower extremity functional scale in post test indicating the recovery of 
selected samples in response to intervention. 
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Graph V– LEFS of Group B 
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TABLE - VII 
Table VII represents the comparative mean values, mean difference, 
standard deviation, and unpaired ‘t’ value between group A and group B on 
lower extremity functional scale. 
 
LEFS Mean 
Mean 
difference 
Standard 
deviation 
Unpaired ‘t’ 
value 
 
Group A 
 
Group B 
 
16.57 
 
31.93 
 
 
15.36 
 
 
3.358 
 
 
12.538 
 
 Table VII shows the analysis of group A and group B with lower 
extremity functional scale .The unpaired ‘t’ value of 12.538  was greater 
than the tabulated ‘t’ value of 2.05 at 0.05 level of significance which 
showed that there was statistically significant difference between group A 
and group B. The mean value of group A was 16.57 and the mean value of 
group B was 31.93, which showed that there was a greater improvement in 
group B than group A. 
Therefore, the study is rejecting the null hypothesis and accepting 
the alternate hypothesis. 
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Graph VI - Mean difference of Group A and Group B – LEFS 
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DISCUSSION 
 
The aim of the study was to compare the effectiveness of external 
electrical muscle stimulation versus Transcutaneous Electrical Muscle 
Stimulator in management of diabetic peripheral neuropathy. 
 
L.Reichestein et.al used external electrical muscle stimulation for 
treatment of patient’s diabetic peripheral neuropathy.41 patients were 
selected and treated. The result showed that external electrical muscle 
stimulation was found to be effective in treatment of diabetic peripheral 
neuropathy.  
 
Rose B et.al used Neuropathy Total Symptom Score-6 (NTSS-6), 
Neuropathy Disability Score (NDS). and external electrical muscle 
stimulation to assess the diabetic peripheral neuropathy. 16 patient with 
diabetic peripheral neuropathy were selected and treated with external 
electrical muscle stimulation. Based on the result the above study was 
conducted.           
 
Per M.Humpert MD et.al also used Neuropathy Total Symptom 
Score-6 (NTSS-6) and Neuropathy Disability Score (NDS) are used as 
parameters.  
 
Based on the results of above studies, it is concluded that 
Neuropathy Total Symptom Score-6 (NTSS-6), Lower Extremity 
Functional Scale and Neuropathy Disability Score (NDS) could be used 
to quantify the pain and functional status in diabetic peripheral 
neuropathy. 
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In the analysis and interpretation of Neuropathy Total Symptom Score-
6 (NTSS-6) in group A: 
 
 The paired‘t’  value of 23.02  was greater than the tabulated paired ‘t’ 
value of 2.15, which showed that there was statistically significant 
difference at 0.05 level of significance and 14 degrees of freedom between 
pre and post results. The pre test mean was 10.86, post test mean was 6.1 
and mean difference was 4.76, which showed improvements regarding 
sensation and functional status in response to transcutaneous electrical nerve 
stimulation   for 4 weeks. 
 
In the analysis and interpretation of Lower Extremity Functional Scale 
in group A: 
 
The paired‘t’ value of 26 was greater than the tabulated paired ‘t’ 
value of 2.15, which showed that there was statistically significant 
difference at 0.05 level of significance and 14 degrees of freedom between 
pre and post results. The pre test mean was 38.73, post test mean was 55.30 
and mean difference was 16.57, which showed improvements regarding 
sensation for 4 weeks. 
 
The above study results support the result of present study in 
which Transcutaneous Electrical nerve Stimulator has got improvement 
in above mentioned parameters in group A patients with diabetic 
peripheral neuropathy.  
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In the analysis and interpretation of Neuropathy Total Symptom 
Score-6 (NTSS-6) in group B: 
The paired‘t’ value of  30.98 was greater than the tabulated paired ‘t’ 
value of 2.15, which showed that there was statistically significant 
difference at 0.05 level of significance and 14 degrees of freedom between 
pre and post results. The pre test mean was 10.40, post test mean was 2.40 
and mean difference was 8, which showed improvements regarding pain and 
functional status in response to external electrical muscle stimulation for 4 
weeks. 
In the analysis and interpretation of Lower Extremity Functional Scale 
B: 
  
The paired‘t’ value of  28.99  was greater than the tabulated paired ‘t’ 
value of 2.15 , which showed that there was statistically significant 
difference at 0.05 level of significance and 14 degrees of freedom between 
pre and post results. The pre test mean was 39.27, post test mean was 71.20 
and mean difference was 31.93, which showed improvements regarding 
Lower Extremity Functional Scale in response to external electrical 
muscle stimulation for 4 weeks. 
 
The study results of l. Reichstein et al .supports the result of 
present study in which external electrical muscle stimulation has got 
improvement in above mentioned parameters in group B patients with 
diabetic peripheral neuropathy. 
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IN THE COMPARISON OF GROUP – A AND GROUP – B: 
 
In the analysis and interpretation of Neuropathy Total Symptom Score-
6 (NTSS-6) between group A and group B: 
 
 In the analysis and interpretation of Neuropathy Total Symptom 
Score-6 (NTSS-6), the unpaired ‘t’ value of 9.92 was greater than the 
tabulated ‘t’ value of 2.05, at 0.05 level of significance and 28 degrees of 
freedom, which showed that there was statistically significant difference 
between pre test Vs post test results of group A and group B. The mean 
value of group A was 4.76, mean value of group B was 8 and mean 
difference was 3.24 which showed that there was significant improvements 
regarding pain and functional status in group B compared to group A in 
response to treatment. 
 
In the analysis and interpretation of Lower Extremity Functional Scale 
between group A and group B: 
 
 In the analysis and interpretation of Lower Extremity Functional 
Scale, the unpaired ‘t’ value of 12.538  was greater than the tabulated ‘t’ 
value of 2.05, at 0.05 level of significance and 28 degrees of freedom, which 
showed that there was statistically significant difference between pre test Vs 
post test results of group A and group B. The mean value of group A was 
16.57, mean value of group B was 31.93 and mean difference was 15.36 
which showed that there was significant improvements regarding Lower 
Extremity Functional Scale in group B compared to group A in response to 
treatment. 
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Based on the statistical analysis and interpretation of the results, the 
present study showed that there was significant improvement regarding pain, 
functional status, Neuropathy Total Symptom Score-6 (NTSS-6) and 
Lower Extremity Functional Scale values in patients with diabetic 
peripheral neuropathy treated with external electrical muscle stimulation    
than with Transcutaneous electrical nerve stimulation  . 
 Therefore, the present study is accepting alternate hypothesis and 
rejecting null hypothesis. 
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REASON FOR IMPROVEMENT FOR EXTERNAL ELECTRICAL 
MUSCLE STIMULATION. 
 
¾ External electrical muscle stimulation activates the dorsal column that 
inhibits the c fibers thus interrupting gating pain in put so there by 
pain is been reduced. 
 
¾ External electrical muscle stimulation suggest a improvement in the 
skin perfusion this due to electrical muscle stimulation act as a neural 
vasodilatation. 
 
¾ The high frequency and twin peak properties of the current produce 
neural vasodilatation on both place of electrode. 
 
¾ Activates large diameter sensory nerve there by inhibits sympathetic 
vasoconstriction neuron activity. 
 
¾ Activates small to medium sized sensory neurons to release 
vasodilatory neurotransmitter. 
 
¾ Electrical muscle stimulation to the lower limb increases the up take 
of carbohydrate in lower limb than voluntary cycling exercise. 
 
¾ Unlike during voluntary contraction the larger motor neuron 
innervating fast twitch fiber is the first one to be activated, owing to 
their larger neuron axon s with low in put resistance against electrical 
muscle stimulation. 
 
¾ External electrical muscle stimulation increases insulin sensitivity and 
GLUT-1 and GLUT-4 distribution is being improved. 
 
¾ Micro vascular blood supply and insulin resistance improved in 
diabetic peripheral neuropathy patients.  
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REASON FOR IMPROVEMENT FOR TRANSCUTANEOUS 
ELECTRICAL NERVE STIMULATION 
 
¾ TENS reduces the conduction velocity of the afferent fibers so there 
by reduces the pain sensation. 
 
¾ The peripheral conduction is slowed the volume of nociceptive traffic 
is reduced and this will reduce over all perception of pain. 
 
¾ TENS releases potent vasodilator, calcitonin which is gene related 
peptide. So there is observed increased in the peripheral blood flow. 
 
 
REASON FOR IMPROVEMENT FOR EXTERNAL           
ELECTRICAL MUSCLE STIMULATION THAN 
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION 
 
¾ External electrical muscle stimulation increases insulin sensitivity and 
GLUT-1 and GLUT-4 distribution is being improved. 
 
 
¾ Micro vascular blood supply and insulin resistance improved in 
diabetic peripheral neuropathy patients.  
 
 
¾ External electrical muscle stimulation activates the dorsal column that 
inhibits the c fibers thus interrupting gating pain in put so there by 
pain is been reduced. 
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SUMMARY AND CONCLUSION 
 
Summary: 
  The objective of the study was to compare the effect of external 
electrical muscle stimulation versus Transcutaneous Electrical Muscle 
Stimulator in management of diabetic peripheral neuropathy. 
To conduct the study, a total number of 30 patients, were selected 
by random sampling method after the consideration of inclusion and 
exclusion criteria. The informed consents were obtained from subjects 
individually. 
  NTSS-6 and LEFS were taken as parameters to measure the 
changes.The pre treatment data were collected for group A and group B 
subjectes and computed. 
  Group A were given TENS  and Group B wrer given external 
electrical muscle stimulation treatment daily. The result of the same 
parameter were recorded for comparison after three weeks of treatment. 
  The paired ‘t’ test was used to compare the pre versus post 
treatment result of Group A and Group B seperately.The unpaired ‘t’test 
was used to compare the mean difference of Group A and Group B. 
      In the analysis and interpretation of Neuropathy Total 
Symptom Score-6 (NTSS-6), the unpaired ‘t’ value of 9.92 was greater 
than the tabulated ‘t’ value of 2.05, at 0.05 level of significance and 28 
degrees of freedom, which showed that there was statistically significant 
difference between pre test Vs post test results of group A and group B. 
The mean value of group A was 4.76, mean value of group B was 8 and 
mean difference was 3.24 which showed that there was significant 
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improvements regarding pain and functional status in group B compared 
to group A in response to treatment. 
                      In the analysis and interpretation of Lower Extremity 
Functional Scale, the unpaired ‘t’ value of 12.538  was greater than the 
tabulated ‘t’ value of 2.05, at 0.05 level of significance and 28 degrees of 
freedom, which showed that there was statistically significant difference 
between pre test Vs post test results of group A and group B. The mean 
value of group A was 16.57, mean value of group B was 31.93 and mean 
difference was 15.36 which showed that there was significant 
improvements regarding Lower Extremity Functional Scale in group B 
compared to group A in response to treatment. 
Conclusion: 
  This study shows that there was reduction in cold, warm ,cold 
pain threshold ,heat pain threshold, vibration perception threshold and 
touch perception threshold diabetic peripheral neuropathy after treatment 
with external electrical muscle stimulation. 
  Thus the study concluded that external electrical muscle 
stimulation is effective treatment for diabetic peripheral neuropathy and 
Neuropathy Total Symptom Score-6 (NTSS-6) and Lower Extremity 
Functional Scale could be used as the assessment tools for cold, warm 
,cold pain threshold ,heat pain threshold, vibration perception threshold 
and touch perception threshold 
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RECOMMENDATIONS 
 
¾ A similar study can be conducted for reducing the blood sugar level in 
type II Diabetic patients. 
 
¾ The Lower Extremity Functional Scale (LEFS) Neuropathy Total 
Symptom Score-6 (NTSS-6) and Neuropathy Disability Score (NDS) 
parameters can be used for other poly neuropathy conditions. 
 
¾ The effectiveness of transcutaneous electrical nerve stimulation in 
reducing the pain in diabetic peripheral neuropathy. 
 
¾ The effectiveness of Transcutaneous electrical nerve stimulation and 
external electrical muscle stimulation in stroke, peripheral nerve lesion 
and neuropathy conditions. 
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APPENDIX 
 
DEFINITION OF TERMS 
 
¾ Diabetic peripheral neuropathy 
 The term Diabetic peripheral neuropathy encompasses a wide range of 
disorders in which the nerves outside of the brain and spinal cord—
peripheral nerves—have been damaged. Peripheral neuropathy may also 
be referred to as peripheral neuritis, or if many nerves are involved, the 
terms polyneuropathy or polyneuritis may be used. 
 
¾ Transcutaneous electrical nerve stimulation (TENS) 
        Transcutaneous electrical nerve stimulation (TENS) is the use of 
electric current produced by a device to stimulate the nerves for 
therapeutic purposes. TENS by definition covers the complete range of 
transcutaneously applied currents used for nerve excitation although the 
term is often used with a more restrictive intent, namely to describe the 
kind of pulses produced by portable stimulators used to treat pain. 
 
¾ External electrical muscle stimulation 
Electrical muscle stimulation (EMS), also known as neuromuscular 
electrical stimulation (NMES) or electromyo stimulation is the elicitation 
of muscle contraction using electric impulses. The impulses are generated 
by a device and delivered through electrodes on the skin in direct 
proximity to the muscles to be stimulated. The impulses mimic the action 
potential coming from the central nervous system, causing the muscles to 
contract. The electrodes are generally pads that adhere to the skin. 
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¾ Neuropathy Total Symptom Score-6(NTSS-6). 
The NTSS-6 questionnaire was developed to evaluate the 
frequency and intensity of individual neuropathy sensory symptoms 
identified frequently by patients with DPN (ie, numbness and/or 
insensitivity; prickling and/or tingling sensation; burning sensation; 
aching pain and/or tightness; sharp, shooting, lancinating pain; and 
allodynia and/or hyperalgesia). 
 
¾ Lower Extremity Functional Scale (LEFS). 
           The Lower Extremity Functional Scale (LEFS) can be used to 
evaluate the functional impairment of a patient with a disorder of one or 
both lower extremities. It can be used to monitor the patient over time 
and to evaluate the effectiveness of an intervention 
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PARAMETER 
 
Neuropathy Total Symptom Score-6 (NTSS-6) 
 
Subjective Peripheral Neuropathy Screen Questionnaire  
Full Name: _________________________________________  
Date: __________  
Please take a few minutes to answer the following questions about the 
feeling in your legs and feet. Check yes or no based on how you usually feel, 
Thank you. 
  
¾ Do you ever have legs and/or feet that feel numb? Yes No.  
¾ Do you ever have any burning pain in your legs and/or feet?         
Yes No.  
¾ Are your feet too sensitive to touch? Yes No  
¾ Do you get muscle cramps in your legs and/or feet? Yes No  
¾ Do you ever have any prickling or tingling feelings in your legs or 
feet? Yes No  
¾ Does it hurt at night or when the covers touch your skin? Yes No  
¾ When you get into the tub or shower, are you unable to tell the hot 
water from the cold water with your feet? Yes No 
¾ Do you ever have any sharp, stabbing, shooting pain in your feet or 
legs? Yes No  
 
¾ Have you experienced an asleep feeling or loss of sensation in your 
legs or feet? Yes No  
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¾ Do you feel weak when you walk? Yes No  
¾  Are your symptoms worse at night? Yes No 
¾  Do your legs and/or feet hurt when you walk? Yes No 
¾  Are you unable to sense your feet when you walk? Yes No 
¾ Is the skin on your feet so dry that it cracks open? Yes No  
¾ Have you ever had electric shock-like pain in your feet or legs? Yes 
No . 
 
The Lower Extremity Functional Scale (LEFS) 
 
Overview: The Lower Extremity Functional Scale (LEFS) can be used to 
evaluate the functional impairment of a patient with a disorder of one or both 
lower extremities. It can be used to monitor the patient over time and to 
evaluate the effectiveness of an intervention. The authors are from 
McMaster University in Hamilton Ontario.  
Patient instructions: Today does you or would you have any difficulty at all 
with these activities?  
Activities (20):  
¾ Any of your usual work housework or school activities  
¾ Your usual hobbies recreational or sporting activities.  
¾ Getting into or out of the bath  
¾ Walking between rooms  
¾ Putting on your shoes or socks  
¾ Squatting  
¾ Lifting an object like a bag of groceries from the floor  
¾ Performing light activities around your home  
¾ Performing heavy activities around your home  
 47
¾ getting into or out of a car  
¾ walking 2 blocks (about 1/6th mile or about 250 meters)  
¾ walking 1 mile (1.6 km)  
¾ going up or down 10 steps (about 1 flight of stairs)  
¾ standing for 1 hour  
¾ sitting for 1 hour  
¾ running on even ground  
¾ running on uneven ground  
¾ making sharp turns while running fast  
¾ hopping  
¾ rolling over in bed  
Response Points 
unable to perform 
activity or extreme 
difficulty 
0 
quite a bit of 
difficulty 
1 
moderate difficulty 2 
a little bit of 
difficulty 
3 
no difficulty 4 
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The Lower Extremity Functional Scale score = sum (points for all 20 
activities)  
Interpretation:  
¾ minimum score: 0  
¾ maximum score: 80  
¾ The lower the score the greater the disability.  
¾ The Minimal Detectable Change (MDC) is 9 scale points.  
• The Minimal clinically Important Difference (MCID) is 9 scale points.  
 Percent of maximal function =  
= (LEFS score) / 80 * 100 
 
TECHNIQUE:  
Type 2 DM patients, who were only treated with a diet and/or oral 
Anti diabetics were included in this 12 week study. After an Introductory 
phase of 2 weeks with the use of an EMS unit, the treatment was given at the 
patient’s disposal. On average, the test Persons used the unit daily during the 
following 4months. 
Alternately the electrodes were placed in the area of the Musculature 
of thighs and the shank. The treatment was given for twenty min for each 
patient.  Each period of application and intensity was recorded by the units.  
 
After this 4months period of treatment the units were given back. The 
course of the above mentioned parameters. A square-wave biphasic pulses of 
0.2-ms duration at a frequency of 20 Hz with a duty cycle of 1-s 
stimulation/1-s pause, because our laboratory has previously reported that 
parameters used can induce the highest o2 with this procedure. Both muscle 
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groups (lower legs and tight) were sequentially stimulated to co contract in 
an isometric manner elicited from an electrical stimulator.  
 
  
      Fig- 1: Treatment given with stimulator. 
 
 
  
   Fig 2:      Treatment given with TENS. 
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INFORMED CONSENT TO PARTICIPATE VOLUNTARILY IN A 
RESEACH INVESTICATION 
 
NAME                    : 
AGE                        : 
SEX                         : 
OCCUPATION      : 
ADDRESS FOR  
COMMUNICATION : 
 
DECLARATION 
I have fully understood the nature and purpose of the study. I accept to 
be a subject in this study. I declare that the above information is true to my 
knowledge. 
 
DATE        :  
PLACE      : 
 
 
Signature of the subject 
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ASSESSMENT  CHART  
 
 
NAME             : 
AGE                 : 
SEX                  : 
SIDE                : 
MODE OF TREATMENT     :  External Electrical Muscle Stimulation 
versus TENS 
 
MEASUREMENT  : 
 
PARAMETER  BEFORE 
TREATMENT 
AFTER TREATMENT 
 
NTSS – 6 
LEFS  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
